What is new in the EAS Consensus Statement on Systemic Metabolic Disorders?

Rates of obesity and related metabolic disorders have increased dramatically in recent years with serious consequences for the long-term health of the population worldwide. Although the interplay between the various metabolic disorders is increasingly recognized, current management strategies often target individual metabolic disorders, limiting the impact of treatment on risk reduction.

The European Atherosclerosis Society (EAS) addresses this issue through a consensus statement that provides a clinically actionable framework based on the pathophysiology of the systemic metabolic disorders associated with excess adiposity. The framework takes a holistic approach to these disorders and is divided into three actionable stages to reflect the progression of the disease. It defines specific clinical criteria and provides management strategies for each stage.

Learning objectives

The Lipid Clinic Network local webinars on the Consensus Statement on Systemic Metabolic Disorders are tailor-made sessions designed to support national dissemination of current trends in obesity and related metabolic disorders and their long-term cardiovascular consequences, explain the pathophysiological links between excess adiposity and systemic metabolic disturbances such as dyslipidaemia and insulin resistance, and recognize the limitations of managing individual risk factors in isolation.

Each webinar is developed in collaboration with local experts to reflect country-specific perspectives, practices, and challenges, ensuring that the Consensus Statement is translated into meaningful, practical insights for clinical implementation.

Join your national webinar to learn how the changes in the Consensus Statement is being applied in your country — and how it can support you in optimizing patient care.

Upcoming webinars

Below you can find the local webinars planned for 2026. Don’t miss the opportunity to register for these tailor-made and insightful sessions.

Acknowledgement

EAS have independently organised all matters related to this activity. The Society gratefully acknowledges financial support in the form of a grant from Novo Nordisk and Recordati.

Previous webinars available on-demand